Immunotherapies to optimize pregnancy outcomes in subfertile women-Reference-Cited by-同舟云学术

Immunotherapies to optimize pregnancy outcomes in subfertile women

Published:2022-05-06 Issue:4 Volume:28 Page:601-602
ISSN:1355-4786
Container-title:Human Reproduction Update
language:en
Short-container-title:

Author:

Cavalcante Marcelo Borges¹²^ORCID,Sarno Manoel³^ORCID,Barini Ricardo⁴^ORCID

Affiliation:

1. Postgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR) , Fortaleza-CE, Brazil

2. CONCEPTUS—Reproductive Medicine , Fortaleza-CE, Brazil

3. Department of Gynecology and Obstetrics, Federal University of Bahia (UFBA) , Salvador-BA, Brazil

4. Department of Obstetrics and Gynecology, State University of Campinas (UNICAMP) , Campinas, Brazil

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Reproductive Medicine

Link

https://academic.oup.com/humupd/article-pdf/28/4/601/44318043/dmac017.pdf

Reference12 articles.

1. The role of immunotherapy in in vitro fertilization and recurrent pregnancy loss: a systematic review and meta-analysis;Achilli;Fertil Steril,2018

2. Lymphocyte immunotherapy in recurrent miscarriage and recurrent implantation failure;Cavalcante;Am J Reprod Immunol,2021

3. Lymphocyte immunotherapy for recurrent miscarriages: predictors of therapeutic success;Cavalcante;Am J Reprod Immunol,2018

4. The endometrial immune profiling may positively affect the management of recurrent pregnancy loss;Cheloufi;Front Immunol,2021

5. Decidualization score identifies an endometrial dysregulation in samples from women with recurrent pregnancy losses and unexplained infertility;Dambaeva;F S Rep,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent miscarriage and infertility: a national service evaluation;Journal of Obstetrics and Gynaecology;2023-08-02

2. The unique expression pattern of human leukocyte antigen in trophoblasts potentially explains the key mechanism of maternal-fetal tolerance and successful pregnancy;Journal of Reproductive Immunology;2023-08

3. Reply: Immunotherapies to optimize pregnancy outcomes in subfertile women;Human Reproduction Update;2022-05-06